1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Otolith Labs

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2015

Location

Washington DC US

Primary Industry

Medical Devices & Equipment

About

Founded in 2015 by Sam Owen (CEO), and based in Washington, DC, US, Otolith Labs, Inc. operates as a developer of prescription medical devices for the treatment of vestibular disorders such as chronic vertigo. In September 2022, Otolith Labs, Inc. raised USD 20 million in Series A funding from new investor Morningside Venture Partners from investors. The firm offers its patented therapeutic technology, which is a medical wearable treatment for vertigo called nVSM (noninvasive Vestibular System Masking) that applies localized mechanical stimulation to the vestibular system through calibrated vibrations to help provide immediate relief to vertigo and other vestibulogenic conditions in patients suffering from vestibular disorders. The company intends to use the September 2022 funding to further develop and support its clinical programs.
Current Investors
Radical Investments, Morningside Venture Partners

Request a demo to show more

Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors, Therapeutic Devices
Website
www.otolithlabs.com
Verticals
Manufacturing, Wearables & Quantified Self
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.